Efficacy, tolerability and safety of darifenacin, an M(3) selective receptor antagonist: an investigation of warning time in patients with OAB - Zinner, N; Susset, J; Gittelman, M; Arguinzoniz, M; Rekeda, L; Haab, F (Int J Clin Pract, 2006)